This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Zhengbang Chen: Innovator in Hepatitis C Virus Resistance
Introduction
Zhengbang Chen is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating viral infections.
Latest Patents
Zhengbang Chen holds a patent for a silicon-containing compound designed for resistance to hepatitis C virus infection. This invention provides a compound represented by a specific formula, along with its pharmaceutically acceptable salts, tautomers, stereoisomers, and deuterated compounds. The patent also outlines a preparation process and a pharmaceutical composition that includes this compound. Furthermore, it details the use of the compound in the treatment of hepatitis C virus infection.
Career Highlights
Zhengbang Chen is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he has been instrumental in advancing research and development in antiviral therapies. His work has contributed to the understanding and potential treatment options for hepatitis C.
Collaborations
Zhengbang Chen has collaborated with notable colleagues, including Yinsheng Zhang and Baomin Liu, to further enhance the research and development efforts in his field.
Conclusion
Zhengbang Chen's innovative work in developing a silicon-containing compound for hepatitis C virus resistance showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against viral infections, highlighting the importance of research and innovation in healthcare.